1. Home
  2. AURA vs PACB Comparison

AURA vs PACB Comparison

Compare AURA & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$6.30

Market Cap

631.6M

Sector

Health Care

ML Signal

HOLD

Logo Pacific Biosciences of California Inc.

PACB

Pacific Biosciences of California Inc.

SELL

Current Price

$2.12

Market Cap

521.8M

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
AURA
PACB
Founded
2007
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
631.6M
521.8M
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
AURA
PACB
Price
$6.30
$2.12
Analyst Decision
Strong Buy
Buy
Analyst Count
6
8
Target Price
★ $16.60
$2.40
AVG Volume (30 Days)
869.6K
★ 15.4M
Earning Date
11-12-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $93,468,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$16.01
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 3.04
52 Week Low
$4.73
$1.07
52 Week High
$9.54
$3.44

Technical Indicators

Market Signals
Indicator
AURA
PACB
Relative Strength Index (RSI) 45.48 55.33
Support Level $6.04 $1.27
Resistance Level $7.18 $2.73
Average True Range (ATR) 0.28 0.28
MACD 0.05 -0.04
Stochastic Oscillator 30.66 23.92

Price Performance

Historical Comparison
AURA
PACB

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.

Share on Social Networks: